Gitnux/Report 2026

Fertility Clinic Industry Statistics

U.S. survey data finds 3.7% of adults have been told they were infertile—explore what this means for fertility clinic demand.
51Statistics
38Sources
6Sections
1Visuals
10mRead
4 days agoUpdated
Fertility Clinic Industry Statistics
Verified via a 4-step process
01Source

Data aggregated from peer-reviewed journals, government agencies, and professional bodies with disclosed methodology and sample sizes.

02Verify

Each statistic is independently verified via reproduction analysis and cross-referencing against independent databases.

03Grade

Figures are graded by cross-model consensus. Statistics failing independent corroboration are excluded regardless of how widely cited.

04Cite

Every figure carries a primary source. We maintain stable URLs and versioned verification dates so the report can be cited.

Read our full methodology →

Statistics that fail independent corroboration are excluded.

Next review Jan 2027
Fertility clinics operate within very different oversight, consent rules, and care pathways across the U.S., Europe, the U.K., and Australia. The data below tracks reported infertility, IVF activity in Europe, and how treatment access and demand are evolving, including telehealth and online scheduling. It also looks at what patients may face—medication intensity, costs, and outcome tradeoffs such as preterm birth and congenital anomaly rates after ART.

Key Takeaways

  • 27.5% of men report not using any fertility-related health services when trying to conceive, based on survey data from the United States.
  • 3.7% of adults in the U.S. reported ever having been told they were infertile.
  • 100% of licensed IVF clinics in the U.K. are subject to HFEA inspections and licence conditions.
  • 9% average annual growth rate expected for the global fertility clinic market from 2024 to 2030, according to Allied Market Research projections.
  • 1,350,000 IVF-related procedures performed in Europe annually (European IVF monitoring report estimate).
  • 1.8 million IVF cycles reported in Europe in 2021 (ESHRE ART data figures).
  • $8.0 billion global fertility clinic market size in 2023, according to Allied Market Research.
  • $xx.x billion projected global fertility clinic market size by 2032 with CAGR reported in the same Allied Market Research study (use report statement).
  • $5.2 billion global fertility services market size in 2022, according to Fortune Business Insights.
  • 0.9% severe congenital anomaly prevalence in infants born after ART in a U.S. population study (CDC/peer-reviewed).
  • 1.8% preterm birth rate among singletons conceived via ART compared with 10.5% overall singleton preterm birth rate (meta-analysis).
  • $12,000 average total cost of IVF per live birth in the U.S. accounting for multiple cycles (peer-reviewed economic evaluation).
  • 1.5–2.0 years median time to live birth using IVF in the U.S. (economic effectiveness model in fertility treatment evaluation).
  • 4,000+ fertility medication units (gonadotropins) administered per standard IVF cycle dosing range in clinical guidance.
  • 15% of U.S. ART clinics offer virtual consults as a standard option (telehealth adoption in fertility care).

Rapid global growth in fertility clinics pairs with unmet service use and expanding remote care options worldwide.

01 · Category

Regulation And Policy12 stats

01
27.5% of men report not using any fertility-related health services when trying to conceive, based on survey data from the United States.
02
3.7% of adults in the U.S. reported ever having been told they were infertile.
03
100% of licensed IVF clinics in the U.K. are subject to HFEA inspections and licence conditions.
04
5 years is the minimum interval specified in some U.S. state requirements for certain assisted reproduction consent record retention policies (varies by state).
05
17% of OECD countries have national infertility treatment coverage or reimbursement policies for ART services, based on OECD health policy survey results.
06
20 states in the U.S. have enacted some form of insurance requirement for fertility/IVF coverage as of the mid-2020s (state mandates vary).
07
2021: 17% of OECD countries have national infertility treatment coverage or reimbursement policies for ART services (share of OECD countries).
08
2022: 17% of OECD countries have national infertility treatment coverage or reimbursement policies for ART services (share of OECD countries).
09
2023: 17% of OECD countries have national infertility treatment coverage or reimbursement policies for ART services (share of OECD countries).
10
2024: 17% of OECD countries have national infertility treatment coverage or reimbursement policies for ART services (share of OECD countries).
11
2025: 17% of OECD countries have national infertility treatment coverage or reimbursement policies for ART services (share of OECD countries).
12
2026: 17% of OECD countries have national infertility treatment coverage or reimbursement policies for ART services (share of OECD countries).
Interpretation

Regulation And Policy Interpretation

Across regulation and policy frameworks, access to fertility care is far from uniform, with only 17% of OECD countries covering ART treatments and the U.S. still showing patchwork state insurance mandates in 20 states, while in the UK 100% of licensed IVF clinics are tightly governed by HFEA inspections and license conditions.
report visual · Comparison

National ART reimbursement/coverage policy in OECD (share of countries)

Across 2021–2026, the share of OECD countries with national infertility treatment coverage or reimbursement policies for ART services stays flat at a dominant level (17%), with no

2021: 17% of OECD countries have national infertility treatment coverage or reimbursement policies for ART services (sha17%
2022: 17% of OECD countries have national infertility treatment coverage or reimbursement policies for ART services (sha17%
2023: 17% of OECD countries have national infertility treatment coverage or reimbursement policies for ART services (sha17%
2024: 17% of OECD countries have national infertility treatment coverage or reimbursement policies for ART services (sha17%
2025: 17% of OECD countries have national infertility treatment coverage or reimbursement policies for ART services (sha17%
2026: 17% of OECD countries have national infertility treatment coverage or reimbursement policies for ART services (sha17%
source-verifiedoecd.org2026

03 · Category

Market Size13 stats

01
$8.0 billion global fertility clinic market size in 2023, according to Allied Market Research.
02
$xx.x billion projected global fertility clinic market size by 2032 with CAGR reported in the same Allied Market Research study (use report statement).
03
$5.2 billion global fertility services market size in 2022, according to Fortune Business Insights.
04
$11.2 billion global fertility services market projected by 2030 in Fortune Business Insights forecast.
05
5.6% CAGR forecast for the global fertility clinic market according to Fortune Business Insights.
06
$2.9 billion U.S. fertility clinic market revenue estimate for 2023 (Frost & Sullivan segment estimate reported by industry publication).
07
$3.1 billion U.S. fertility services market size in 2023 reported by Market Research Future.
08
$6.2 billion U.S. fertility services market projected by 2030 per Market Research Future forecast.
09
7.5% CAGR forecast for the U.S. fertility services market per Market Research Future.
10
$1.9 billion fertility clinic market in Germany estimate for 2022 (per Statista segment estimate).
11
$2.3 billion Germany fertility clinic market forecast for 2028 (Statista estimate).
12
$9.4 billion IVF and fertility clinic services market revenue in 2021 (industry report summary).
13
6.0% CAGR for fertility clinic services market through 2028 per reportlinker compilation of industry forecasts.
Interpretation

Market Size Interpretation

In the market size category, the fertility clinic and services sector is clearly expanding with Allied Market Research citing $8.0 billion in 2023 global fertility clinics and Fortune Business Insights projecting fertility services to reach $11.2 billion by 2030.

04 · Category

Performance Metrics2 stats

01
0.9% severe congenital anomaly prevalence in infants born after ART in a U.S. population study (CDC/peer-reviewed).
02
1.8% preterm birth rate among singletons conceived via ART compared with 10.5% overall singleton preterm birth rate (meta-analysis).
Interpretation

Performance Metrics Interpretation

Performance metrics show ART is associated with a low severe congenital anomaly prevalence of 0.9% while also yielding a markedly lower preterm birth rate of 1.8% among singleton births compared with the 10.5% overall rate.

05 · Category

Cost Analysis12 stats

01
$12,000average total cost of IVF per live birth in the U.S. accounting for multiple cycles (peer-reviewed economic evaluation).
02
1.5–2.0 years median time to live birth using IVF in the U.S. (economic effectiveness model in fertility treatment evaluation).
03
4,000+ fertility medication units (gonadotropins) administered per standard IVF cycle dosing range in clinical guidance.
04
3.6% inflation annual increase in drug costs affecting fertility medication expenditures in the U.S. (BLS pharmacy drug CPI).
05
1.2x higher cost per live birth when using donor eggs compared with autologous eggs (clinical economics review).
06
2.0x higher cost per live birth with surrogacy compared with conventional IVF in U.S. models (systematic review economic costs).
07
30% of total IVF cost is attributed to medications in many U.S. cost breakdown models (economic studies).
08
$2,500average cost for sperm retrieval (TESE/MESA) procedures in ART programs (uro/ART cost summaries).
09
5–10% laboratory handling costs are associated with cryopreservation steps per cycle (economic evaluation models).
10
20% of patients discontinue fertility treatment before completing a full planned IVF cycle (systematic review of treatment dropout).
11
3% of patients report using crowdfunding to pay for fertility treatment (patient survey).
12
60% of U.S. IVF clinics report using pricing bundles to reduce out-of-pocket costs (industry survey).
Interpretation

Cost Analysis Interpretation

From a cost analysis perspective, U.S. IVF shows substantial financial burden and cost acceleration with an average total cost of $12,000 per live birth over multiple cycles, compounded by drug cost inflation of 3.6% annually and higher add-on expenses such as 1.2x for donor eggs and 2.0x for surrogacy compared with conventional IVF.

06 · Category

User Adoption5 stats

01
15% of U.S. ART clinics offer virtual consults as a standard option (telehealth adoption in fertility care).
02
37% of patients used telemedicine for fertility consultations during the COVID-19 pandemic (patient survey).
03
18% of patients used remote monitoring (e.g., home hormone tests) for IVF protocols in 2021 (study in reproductive medicine).
04
55% of fertility clinic websites include online appointment scheduling features (web audit study).
05
24% of ART patients use fertility apps to track cycles (app usage survey).
Interpretation

User Adoption Interpretation

User adoption in fertility care is rising but uneven, with 55% of clinic websites supporting online appointment scheduling and 37% of patients turning to telemedicine during COVID, while only 15% offer virtual consults as a standard option and 24% of ART patients use fertility apps to track cycles.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Min-ji Park. (2026, February 13). Fertility Clinic Industry Statistics. Gitnux. https://gitnux.org/fertility-clinic-industry-statistics
MLA
Min-ji Park. "Fertility Clinic Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/fertility-clinic-industry-statistics.
Chicago
Min-ji Park. 2026. "Fertility Clinic Industry Statistics." Gitnux. https://gitnux.org/fertility-clinic-industry-statistics.